Recognizing Prescription Drug Misuse
Hours: 0.50
Many people take their medications as instructed. However, many people acquire drugs illegally, use drugs that have not been prescribed for them, use more than the recommended dosage, or misuse medications for purposes other than how they were intended to be used. The misuse of prescription medications alone costs the country at least $78.5 billion annually, according to the National Center for Injury Prevention and Control (Ryan & Rosa, 2020). Healthcare professionals need to be knowledgeable about the most frequently misused prescription drugs, trends in drug misuse among Americans, and the interventions being used to combat this epidemic in the U.S. healthcare system.
The goal of this course is to equip nurses, pharmacists, physician assistants, and physicians in the acute care setting with knowledge about the misuse of prescription drugs, the most commonly misused medications, at-risk populations, and the interventions being used to combat the misuse of prescription drugs.
Many people take their medications as instructed. However, many people acquire drugs illegally, use drugs that have not been prescribed for them, use more than the recommended dosage, or misuse medications for purposes other than how they were intended to be used. The misuse of prescription medications alone costs the country at least $78.5 billion annually, according to the National Center for Injury Prevention and Control (Ryan & Rosa, 2020). Healthcare professionals need to be knowledgeable about the most frequently misused prescription drugs, trends in drug misuse among Americans, and the interventions being used to combat this epidemic in the U.S. healthcare system. The goal of this course is to equip nurses, pharmacists, physician assistants, and physicians in the acute care setting with knowledge about the misuse of prescription drugs, the most commonly misused medications, at-risk populations, and the interventions being used to combat the misuse of prescription drugs.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-22-042-H03-P
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-22-042-H03-T
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 0.50 Nursing Contact Hours after successfully completing this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 0.50 contact hours.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
Michigan Board of Nursing
Michigan Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Michigan Board of Pharmacy
Michigan Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 0.50 contact hours.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
New Mexico Medical Board
Physicians will receive 0.50 AMA PRA category 1 Credits™.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™
Recall the definition of prescription drug misuse, the most commonly misused drug classifications, and two at-risk populations.
Name factors associated with prescription drug misuse, clinical indications regarding patient drug misuse, and national programs developed to reduce prescription drug diversion.
Outline:
Section 2: The Stealthy and Destructive Misuse of Prescription Drugs
High-Risk Drugs and Their Societal Burden
Factors Associated with Misuse
Subject Matter Expert: Andrea Powell, RN, BSN
Andrea Powell, RN, BSN is a SME writer for Relias with a focus on acute care. She has over 11 years of clinical nursing experience, spanning across multiple nursing specialties. Her primary focus has been in critical care, with an affinity to surgical nursing. She also has experience in intraoperative nursing and post-anesthesia care. Andrea has served as a clinical team leader, preceptor and charge nurse to colleagues throughout her nursing career. She has a passion for the education of healthcare professionals and an aspiration for excellence in the healthcare delivery system.
The target audience for this course is: Nurses; Pharmacists; Physician Assistants; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
